SCHEMBL6554972

SCHEMBL6554972

COc1cc(OC)cc(/C(C)=C/C=O)c1

nearest known ligand 0.55

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
NQO2 P16083 3/20 0.44
ALDH1A1 P00352 2/20 0.44
ABCG2 Q9UNQ0 1/20 0.43
PDE4A P27815 3/20 0.41
PDE4B Q07343 3/20 0.41
PDE4C Q08493 3/20 0.41
PDE4D Q08499 3/20 0.41
CYP1A1 P04798 1/20 0.40
CYP1B1 Q16678 1/20 0.40
GAA P10253 2/20 0.40
KDM4E B2RXH2 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.39
MEN1 O00255 1/20 0.38
MAPK1 P28482 1/20 0.38
KMT2A Q03164 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
PTGS1 P23219 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6554966 1.00 NQO2 (0.44) NQO2ALDH1A1ABCG2PDE4APDE4B
SCHEMBL24554791 0.82 CES2 (0.58) ALDH1A1ABCG2PDE4APDE4BPDE4C
SCHEMBL3071944 0.80 NQO2 (0.53) NQO2ALDH1A1KDM4EPTGS1
SCHEMBL4962948 0.80 NQO2 (0.53) NQO2ALDH1A1KDM4EPTGS1
SCHEMBL9520221 0.80 NQO2 (0.53) NQO2ALDH1A1KDM4EPTGS1
SCHEMBL28235566 0.72 TPMT (0.44) ALDH1A1GAAKMT2A
SCHEMBL6555550 0.72 TPMT (0.44) ALDH1A1GAAKMT2A
SCHEMBL6555554 0.72 TPMT (0.44) ALDH1A1GAAKMT2A
SCHEMBL6553870 0.72 NQO2 (0.44) NQO2ALDH1A1ABCG2PDE4APDE4B
SCHEMBL6553874 0.72 NQO2 (0.44) NQO2ALDH1A1ABCG2PDE4APDE4B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1149067-B1 7-ARYL-6(Z)HEPTATRIENOIC ACID RETINAMIDES AS APOPTOSIS INDUCING COMPOUNDS AND THEIR USE AS ANTI-CANCER AGENTS HOFFMANN LA ROCHE (CH) 2004-02-25 EP disclosed
EP-1149067-A1 7-ARYL-6(Z)HEPTATRIENOIC ACID RETINAMIDES AS APOPTOSIS INDUCING COMPOUNDS AND THEIR USE AS ANTI-CANCER AGENTS F. HOFFMANN-LA ROCHE AG (CH) 2001-10-31 EP disclosed
US-6310247-B1 HAS APOPTOTIC ACTIVITY USEFUL FOR PROPHYLAXIS AND THERAPY OF CANCER HOFFMANN-LA ROCHE INC. 2001-10-30 US disclosed
WO-2000035856-A1 7-ARYL-6(Z)HEPTATRIENOIC ACID RETINAMIDES AS APOPTOSIS INDUCING COMPOUNDS AND THEIR USE AS ANTI-CANCER AGENTS F. HOFFMANN-LA ROCHE AG (CH) 2000-06-22 WO disclosed